The burden of endometriosis on quality of life in Danish women: an analysis of the Danish Blood Donor Study
- PMID: 41088343
- PMCID: PMC12523183
- DOI: 10.1186/s12916-025-04398-z
The burden of endometriosis on quality of life in Danish women: an analysis of the Danish Blood Donor Study
Abstract
Background: Endometriosis is a complex condition with a wide range of comorbidities. It is widely underdiagnosed, with a diagnostic delay of 4 to 10 years, potentially leading to worsened disease progression and a higher burden of comorbidities affecting quality of life. Understanding the link between endometriosis and its comorbidities is essential for improving early detection of the disease.
Methods: We analysed data from 953 women with a clinical diagnosis of endometriosis and 23,652 age-matched female controls enrolled in the Danish Blood Donor Study, using a case-control design. Participants completed one to four questionnaires covering a wide range of potential comorbidities; genetic data were available for a subset of participants. First, we compared the potential comorbidities between women with endometriosis and controls. Next, we investigated whether a polygenic score (PGS) for endometriosis was associated with those comorbidities. Lastly, we investigated whether women with a high genetic burden of endometriosis (highest PGS decile) experienced similar comorbidities to those diagnosed with endometriosis.
Results: Women with endometriosis experienced challenges in conception, gastrointestinal symptoms, and disturbed sleep patterns, compared to age-matched controls. The endometriosis PGS showed to be a predictor for endometriosis (OR per unit PGS = 1.43, 95% CI = 1.32-1.55). Gastrointestinal symptoms were also nominally associated with the endometriosis PGS, suggesting shared genetic pathways. Women without a diagnosis of endometriosis but with a high genetic burden of endometriosis did not suffer from the same wide range of comorbidities as women diagnosed with endometriosis.
Conclusions: Our findings highlight the complex genetic and clinical relationships between endometriosis and its comorbidities, emphasizing the need for future research investigating potential endometriosis subtypes.
Keywords: Comorbidities; Endometriosis; Genetic burden; Polygenic score.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The DBDS has the necessary permissions and approval from the Danish Data Protection Agency (2007–58-0015) and the Scientific Ethical Committee system (M-20090237). Consent to participate: All participants provided informed oral and written consent to participate. Consent for publication: Not applicable. Competing interests: CLH received research support from Novo Nordisk Foundataion (grant no. NNF22OC0074080) and lecture fees from BMS, Janssen, Tillotts, Servier, and Merck. All other authors do not report any conflicts of interest.
Figures
References
-
- Shafrir AL, Farland LV, Shah DK, et al. Risk for and consequences of endometriosis: a critical epidemiologic review. Best Pract Res Clin Obstet Gynaecol. 2018;51:1–15. - PubMed
-
- Zondervan KT, Cardon LR, Kennedy SH. What makes a good case–control study? Design issues for complex traits such as endometriosis. Hum Reprod. 2002;17:1415–23. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
